ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Pulmonary Disease

Top Pulmonary Disease Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES MEYER MD

Pulmonary Disease

7,323

$509K

463
375 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 59%

$70
Average prescription price

Avg: $255

MARTIN ZAMORA MD

Pulmonary Disease

3,405

$720K

89
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 59%

$211
Average prescription price

Avg: $255

DOUGLAS TANGEL M.D.

Pulmonary Disease

3,235

$279K

329
245 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 59%

$86
Average prescription price

Avg: $255

CHARLES VANHOOK M.D.

Pulmonary Disease

3,212

$384K

357
282 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 59%

$120
Average prescription price

Avg: $255

JAMES ELLIS MD

Pulmonary Disease

2,766

$336K

287
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 59%

$121
Average prescription price

Avg: $255

JAMES GRADY M.D.

Pulmonary Disease

1,738

$244K

152
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 59%

$140
Average prescription price

Avg: $255

ERIC STEVENS M.D.

Pulmonary Disease

1,665

$464K

213
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 59%

$279
Average prescription price

Avg: $255

KELLI JANATA DO

Pulmonary Disease

1,411

$289K

171
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 59%

$205
Average prescription price

Avg: $255

STEVEN LOMMATZSCH M.D.

Pulmonary Disease

1,374

$217K

182
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 59%

$158
Average prescription price

Avg: $255

RICHARD MILCHAK MD

Pulmonary Disease

1,345

$443K

212
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 59%

$329
Average prescription price

Avg: $255

BARRY MAKE MD

Pulmonary Disease

1,333

$247K

143
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 59%

$186
Average prescription price

Avg: $255

PHILIPPE LOPEZ M.D.

Pulmonary Disease

1,281

$159K

151
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 59%

$124
Average prescription price

Avg: $255

JAMES GOOD M.D.

Pulmonary Disease

1,213

$275K

161
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 59%

$227
Average prescription price

Avg: $255

STEPHEN TELATNIK MD

Pulmonary Disease

1,198

$301K

113
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 59%

$251
Average prescription price

Avg: $255

E CANHAM MD

Pulmonary Disease

1,179

$178K

142
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 59%

$151
Average prescription price

Avg: $255

DENNIS LYU MD

Pulmonary Disease

1,177

$322K

78
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 59%

$274
Average prescription price

Avg: $255

ROBERT JANATA DO

Pulmonary Disease

1,156

$254K

143
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 59%

$220
Average prescription price

Avg: $255

VALDEMAR LINDQUIST M.D.

Pulmonary Disease

1,115

$161K

130
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 59%

$145
Average prescription price

Avg: $255

CHRISTOPHER BATES MD

Pulmonary Disease

1,004

$207K

195
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 59%

$206
Average prescription price

Avg: $255

JOEL BECHTEL M.D.

Pulmonary Disease

993

$171K

169
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 59%

$172
Average prescription price

Avg: $255

JOSEPH FORRESTER M.D.

Pulmonary Disease

978

$172K

119
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 59%

$176
Average prescription price

Avg: $255

KRISTIN WALLICK M.D.

Pulmonary Disease

937

$120K

121
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 59%

$128
Average prescription price

Avg: $255

REBECCA MORTENSON - MEESE MD

Pulmonary Disease

932

$244K

177
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 59%

$262
Average prescription price

Avg: $255

JOHN NEWCOMER MD

Pulmonary Disease

928

$224K

188
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

93%
prescriptions for brand name drugs

Avg: 59%

$241
Average prescription price

Avg: $255

DAVID KUKAFKA M.D.

Pulmonary Disease

920

$160K

150
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 59%

$174
Average prescription price

Avg: $255

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank